Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Adherence to guidelines for the prevention of HIV-related respiratory diseases.

Montaner JS, Phillips P, Zala C, Craib KJ, O'Shaughnessy MV, Schechter MT.

Eur Respir J. 1996 Nov;9(11):2318-22.

2.

Influenza and pneumococcal vaccination of HIV-infected patients: a policy analysis.

Rose DN, Schechter CB, Sacks HS.

Am J Med. 1993 Feb;94(2):160-8.

PMID:
8094271
3.

Adherence to guidelines for antiretroviral therapy and for preventing opportunistic infections in HIV-infected adults and adolescents in Ryan White-funded facilities in the United States.

Kaplan JE, Parham DL, Soto-Torres L, van Dyck K, Greaves JA, Rauch K, Ellis B, Amandus HE.

J Acquir Immune Defic Syndr. 1999 Jul 1;21(3):228-35.

PMID:
10421247
4.

Preventive care among HIV-positive patients in a general medicine practice.

Gifford AL, McPhee SJ, Fordham D.

Am J Prev Med. 1994 Jan-Feb;10(1):5-9.

PMID:
7909673
5.

Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients.

Breiman RF, Keller DW, Phelan MA, Sniadack DH, Stephens DS, Rimland D, Farley MM, Schuchat A, Reingold AL.

Arch Intern Med. 2000 Sep 25;160(17):2633-8.

PMID:
10999977
7.

Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.

Jones JL, Hanson DL, Dworkin MS, Alderton DL, Fleming PL, Kaplan JE, Ward J.

MMWR CDC Surveill Summ. 1999 Apr 16;48(2):1-22.

PMID:
12412613
8.
9.
10.

Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Pulmonary Complications of HIV Infection Study Group.

Markowitz N, Hansen NI, Wilcosky TC, Hopewell PC, Glassroth J, Kvale PA, Mangura BT, Osmond D, Wallace JM, Rosen MJ, Reichman LB.

Ann Intern Med. 1993 Aug 1;119(3):185-93.

PMID:
8100692
12.

Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study.

Hoover DR, Saah AJ, Bacellar H, Phair J, Detels R, Anderson R, Kaslow RA.

N Engl J Med. 1993 Dec 23;329(26):1922-6.

13.

Pneumococcal vaccination in HIV-1-infected adults in Uganda: humoral response and two vaccine failures.

French N, Gilks CF, Mujugira A, Fasching C, O'Brien J, Janoff EN.

AIDS. 1998 Sep 10;12(13):1683-9.

PMID:
9764789
14.

Incidence of tuberculosis in the United States among HIV-infected persons. The Pulmonary Complications of HIV Infection Study Group.

Markowitz N, Hansen NI, Hopewell PC, Glassroth J, Kvale PA, Mangura BT, Wilcosky TC, Wallace JM, Rosen MJ, Reichman LB.

Ann Intern Med. 1997 Jan 15;126(2):123-32.

PMID:
9005746
15.

Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups.

Ledergerber B, Mocroft A, Reiss P, Furrer H, Kirk O, Bickel M, Uberti-Foppa C, Pradier C, D'Arminio Monforte A, Schneider MM, Lundgren JD; Eight European Study Groups.

N Engl J Med. 2001 Jan 18;344(3):168-74.

17.
18.

Use of therapeutic and prophylactic drugs for AIDS by homosexual and bisexual men in three US cities.

Holmberg SD, Conley LJ, Buchbinder SP, Judson FN, Bush TJ, Katz MH, Penley KA, Hershow RC.

AIDS. 1993 May;7(5):699-704.

PMID:
8318177
19.

Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study.

Furrer H, Egger M, Opravil M, Bernasconi E, Hirschel B, Battegay M, Telenti A, Vernazza PL, Rickenbach M, Flepp M, Malinverni R.

N Engl J Med. 1999 Apr 29;340(17):1301-6.

20.

Pneumonia in HIV-infected patients in the HAART era: incidence, risk, and impact of the pneumococcal vaccination.

López-Palomo C, Martín-Zamorano M, Benítez E, Fernández-Gutiérrez C, Guerrero F, Rodríguez-Iglesias M, Girón-González JA.

J Med Virol. 2004 Apr;72(4):517-24.

PMID:
14981752
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk